3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
2
Lung Neoplasms
2
Barrett Esophagus
2
Triple Negative Breast Neoplasms
1
Thyroid Nodule
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Neoplasm Metastasis
1
Liver Cirrhosis
1
Hypertension, Portal
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Cysts
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Calcinosis
1
Breast Neoplasms
1
Breast Cyst
1
Arachnodactyly
1
Adenocarcinoma of Lung
1
Interventions
Oxaliplatin
19
pembrolizumab
13
Fluorouracil
12
Leucovorin
11
Capecitabine
11
Paclitaxel
10
Gemcitabine
8
Docetaxel
8
zolbetuximab
6
cemiplimab
6
Cisplatin
6
Albumin-Bound Paclitaxel
6
durvalumab
5
Ramucirumab
5
Radiotherapy
5
Irinotecan
4
Cyclophosphamide
4
130-nm albumin-bound paclitaxel
4
trastuzumab deruxtecan
3
tislelizumab
3
lenvatinib
3
enzalutamide
3
darolutamide
3
Trastuzumab
3
Taxes
3
S 1 (combination)
3
Radiosurgery
3
Pemetrexed
3
Nivolumab
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Diagnostic Imaging
×
1 year
×
Clear all
No trials found.